Chester Clinic

 

United kingdom-larkhall: pharmaceutical products

OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure This notice in TED website: United Kingdom-Larkhall: Pharmaceutical products
Directive 2004/18/EC
Section I: Contracting authority
I.1)
Name, addresses and contact point(s)
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority')
National Procurement, Canderside, 2 Swinhill Avenue
Contact point(s): National Procurement
For the attention of: Stuart Gillespie
ML9 2QX Larkhall
UNITED KINGDOM
Telephone: +44 1698794585
Internet address(es):
Address of the buyer profile: Electronic submission of tenders and requests to participate:
Further information can be obtained from: The above mentioned contact point(s)
Specifications and additional documents (including documents for competitive dialogue and a dynamic
purchasing system) can be obtained from: The above mentioned contact point(s)
Tenders or requests to participate must be sent to: The above mentioned contact point(s)
Type of the contracting authority
Body governed by public law
Contract award on behalf of other contracting authorities
The contracting authority is purchasing on behalf of other contracting authorities: yes
Golden Jubilee Hospital (National Waiting Times Centre Board)
NHS 24
NHS Ayrshire and Arran
NHS Borders
NHS Dumfries and Galloway
NHS Education for Scotland
NHS Fife
NHS Forth Valley
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure NHS GrampianNHS Greater Glasgow and ClydeNHS Health ScotlandNHS HighlandNHS LanarkshireNHS LothianNHS OrkneyHealthcare Improvement ScotlandNHS ShetlandNHS TaysideNHS Western IslesScottish Ambulance ServiceThe Common Services Agency for the Scottish Health ServiceThe State Hospital for ScotlandAll entities constituted pursuant to the National Health Service (Scotland) Act 1978, (i.e. all NHS Scotland HealthBoards, Special Health Boards and the Authority or other NHS organisation established pursuant to the NHS(Scotland) Act 1978) and any Integrated Joint Boards established pursuant to the new Public Bodies (JointWorking) Scotland Act 2014.
Section II: Object of the contract
II.1)
Title attributed to the contract by the contracting authority:
Oncology dose banding.
Type of contract and location of works, place of delivery or of performance
Supplies
Purchase
Main site or location of works, place of delivery or of performance: Any or all locations of all NHS Scotland
Health Boards, all NHS Scotland Special Health Boards and/or the Authority or other NHS organisation
established pursuant to the NHS (Scotland) Act 1978 and any Integrated Joint Boards established pursuant
to the new public bodies (joint working) Scotland Act 2014 (altogether hereinafter referred to as ‘NHS
Scotland').
NUTS code UKM
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The notice involves the establishment of a framework agreement
Information on framework agreement
Framework agreement with a single operator
Duration of the framework agreement
Duration in months: 36
Estimated total value of purchases for the entire duration of the framework agreement
Estimated value excluding VAT:
Range: between 60 000 000 and 65 000 000 GBP
Short description of the contract or purchase(s)
This Framework Agreement is for the supply of unlicensed, ready to use, cytotoxic medicines in syringe and
infusion bags to NHS Scotland. The medicines to be supplied under this contract are Bortezomib, Carboplatin,
Cetuximab, Cisplatin, Cyclophosphamide, Cytarabine, Docetaxel, Doxorubicin, Epirubicin, Fluorouracil,
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure Gemcitabine, Irinotecan, Methotrexate, Oxaliplatin, Paclitaxel, Pemetrexed, Rituximab,Trastuzumab andVincristine in a range of doses.
Note: The buyer is using PCS-Tender to carry out this procurement process. Please note this is a separatewebsite and if you are not already registered, registration will be required.
To access PCS-Tender, record your interest in this notice and access the tender documentation please visit and search for project Code project_2593under PQQs Open to All Suppliers or ITTs Open to All Suppliers as appropriate. Please use the search/filterfunction, then select Project Code from the drop-down. Please note that once you have expressed interest in thePQQ/ITT it will move to your My PQQs/My ITTs area.
If you have already registered on Public Contracts Scotland and PCS-Tender and paired your accounts you canaccess PCS-Tender through your Public Contracts Scotland Control Panel.
Common procurement vocabulary (CPV)
33600000, 33652000, 33650000, 33690000
Information about Government Procurement Agreement (GPA)
The contract is covered by the Government Procurement Agreement (GPA): yes
Lots
This contract is divided into lots: yes
Tenders may be submitted for one or more lots
Information about variants
Variants will be accepted: no
Quantity or scope of the contract
Total quantity or scope:
This framework agreement is for the supply of unlicensed, dose banded, ready to use cytotoxic medicines to
NHS Scotland.
The framework agreement will consist of 20 lots with a single supplier being appointed to each Lot. The doses
and quantities are detailed in the tender documentation.
Estimated value excluding VAT:
Range: between 60 000 000 and 65 000 000 GBP
Information about options
Options: yes
Description of these options: The Authority is entitled at its sole discretion to extend the 36 month duration of the
Framework Agreement by 1 period of up to 12 months by giving a minimum of 3 months written notice of such
extension.
Information about renewals
This contract is subject to renewal: no
Duration of the contract or time limit for completion
Duration in months: 36 (from the award of the contract)
Information about lots
Lot No: 2
Lot title: Cetuximab
1)
Short description
Supply of Cetuximab in a range of doses in Infusion bags.
Common procurement vocabulary (CPV)
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure Quantity or scope
Supply of Cetuximab in a range of doses in infusion bags. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT
Lot No: 12Lot title: Irinotecan1) Short description
Supply of Irinotecan in a range of doses in Infusion bags.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Irinotecan in a range of doses in infusion bags. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to the ITT.
Lot No: 6Lot title: Cytarabine1) Short description
Supply of Cytarabine solution in a Luer Lok syringe.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Cytarabine solution in a Luer Lok syringe. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 7Lot title: Docetaxel1) Short description
Supply of Docetaxel in a range of doses in Infusion bags.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Docetaxel in a range of doses in infusion bags. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 8Lot title: Doxorubicin1) Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure Supply of Doxorubicin in a range of doses in Leur-Lok syringe.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Doxorubicin in a range of doses in Leur-Lok syringe. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 9Lot title: Epirubicin1) Short description
Supply of Epirubicin in a range of doses in Leur-Lok syringe.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Epirubicin in a range of doses in Leur-Lok syringe. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 10Lot title: Fluorouracil1) Short description
Supply of Fluorouracil in a range of doses in Leur-Lok syringe.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Fluorouracil in a range of doses in Leur-Lok syringe. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 11Lot title: Gemcitabine1) Short description
Supply of Gemcitabine in a range of doses in infusion bags.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Gemcitabine in a range of doses in infusion bags. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure Lot No: 13Lot title: Methotrexate Intrathecal Prefilled Syringe1) Short description
Supply of Methotrexate in syringe for intrathecal use.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Methotrexate in syringe for intrathecal use. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 14Lot title: Methotrexate1) Short description
Supply of Methotrexate in a range of doses in Leur Lok syringe.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Methotrexate in a range of doses in Leur Lok syringe. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 15Lot title: Oxaliplatin1) Short description
Supply of Oxaliplatin in a range of doses in infusion bags.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Oxaliplatin in a range of doses in infusion bags. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to the ITT.
Lot No: 16Lot title: Paclitaxel1) Short description
Supply of Paclitaxel in a range of doses in infusion bags.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Paclitaxel in a range of doses in infusion bags.
Indication about different date for duration of contract or starting/completion
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure Additional information about lots
Please refer to ITT.
Lot No: 18Lot title: Rituximab1) Short description
Supply of Rituximab in a range of doses in infusion bags.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Rituximab in a range of doses in infusion bags. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 19Lot title: Trastuzumab1) Short description
Supply of Trastuzumab in a range of doses in infusion bags.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Trastuzumab in a range of doses in infusion bags. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 20Lot title: Vincristine1) Short description
Supply of Vincristine in a range of doses in infusion bags and Luer Lok syringes.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Vincristine in a range of doses in Infusion Bags and Luer Lok syringes. Doses and quantities are
detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 3Lot title: Carboplatin1) Short description
Supply of Carboplatin in a range of doses in infusion bags.
Common procurement vocabulary (CPV)
33600000
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure Quantity or scope
Supply of Carboplatin in a range of doses in infusion bags. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 4Lot title: Cisplatin1) Short description
Supply of Cisplatin in a range of doses in Leur-Lok syringe.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Cisplatin in a range of doses in Leur-Lok syringe. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 17Lot title: Pemetrexed1) Short description
Supply of Pemetrexed in a range of doses in infusion bags.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Pemetrexed in a range of doses in Infusion Bags. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 1Lot title: Bortezomib1) Short description
Supply of Bortezomib in a range of doses in Leur-Lok syringe.
Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Bortezomib in a range of doses in Leur-Lok syringe. Doses and quantities are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Lot No: 5Lot title: Cyclophosphamide1) Short description
Supply of Cyclophosphamide in a range of doses in Infusion Bags and Leur-Lok syringe.
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure Common procurement vocabulary (CPV)
33600000
Quantity or scope
Supply of Cyclophosphamide in a range of doses in Infusion Bags and Leur-Lok syringe. Doses and quantities
are detailed in the ITT.
Indication about different date for duration of contract or starting/completion
Additional information about lots
Please refer to ITT.
Section III: Legal, economic, financial and technical information
III.1)
Conditions relating to the contract
Deposits and guarantees required:
Main financing conditions and payment arrangements and/or reference to the relevant provisions
governing them:
Legal form to be taken by the group of economic operators to whom the contract is to be awarded:
The Prime Contractor shall be liable in the event of a consortium bid.
Other particular conditions
The performance of the contract is subject to particular conditions: no
Conditions for participation
Personal situation of economic operators, including requirements relating to enrolment on professional
or trade registers
Information and formalities necessary for evaluating if the requirements are met: In accordance with the Public
Contracts (Scotland) Regulations 2012 the Authority shall treat as ineligible and shall not select any economic
operator if 1 of more of the grounds set out below apply. Accordingly economic operators must in each case
confirm whether or not the economic operator, any of its directors or any other person who has power of
representation, decision or control over the economic operator has been convicted of any of the following
offences:
(a) the common law offence of conspiracy where that conspiracy relates to participation in a criminal
organisation as defined in Article 2 of Council Framework Decision 2008/841/JHA or an offence under sections
28 or 30 of the Criminal Justice and Licensing (Scotland) Act 2010;
(b) corruption within the meaning of section 1 (2) of the Public Bodies Corrupt Practices Act 1889 or section 1
of the Prevention of Corruption Act 1906, where the offence relates to active corruption as defined in Article 3 of
the Council Act of 26th May 1997 and Article 3(1) of Council Joint Action 98/742/JHA;
(c) bribery or corruption within the meaning of sections 68 and 69 of the Criminal Justice (Scotland) Act 2003
where the offence relates to active corruption, or bribery within the meaning of sections 1 or 6 of the Bribery Act
2010;
(d) the common law offence of incitement to commit a crime;
(e) fraud, where the offence relates to fraud affecting the financial interests of the European Communities
as defined by Article 1 of the Convention relating to the protection of the financial interests of the European
Communities, within the meaning of:
(i) the offence of cheating the Revenue;
(ii) the common law offence of fraud;
(iii) the common law offence of theft or fraud;
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure (iv) fraudulent trading within the meaning of section 458 of the Companies Act 1985 or section 993 of theCompanies Act 2006;(v) fraudulent evasion within the meaning of section 170 of the Customs and Excise Management Act 1979 orsection 72 of the Value Added Tax Act 1994;(vi) an offence in connection with taxation in the European Union within the meaning of section 71 of theCriminal Justice Act 1993;(vii) the common law offence of uttering; or(viii) the common law offence of attempting to pervert the course of justice;(f) money laundering within the meaning of section 340 (11) of the Proceeds of Crime Act 2002 or the MoneyLaundering Regulations 2007, or an offence in connection with proceeds of drug trafficking within the meaningof sections 49, 50 or 51 of the Drug Trafficking Act 1994; or.
(g) any other offence within the meaning of Article 45 (1) of the Public Sector Directive as defined by thenational law of any relevant state.
In accordance with the Public Contracts (Scotland) Regulations 2012 the Authority may treat as ineligible ordecide not to select any economic operator if one or more of the grounds set out below apply. Accordinglyeconomic operators must in each case confirm whether or not any of the following apply, namely:(a) Has the economic operator been declared bankrupt?(b) Has the economic operator has a debt relief order made against it/him/her?(c) Has the economic operator had a receiving order or an administration order or bankruptcy restrictions orderor a debt relief restriction order made against it/him/her?(d) Has the economic operator made any composition or arrangement with or for the benefit of creditors ormade any conveyance or assignation for the benefit of its creditors?(e) Has the economic operator appeared unable to pay or has no reasonable prospects of being able to pay adebt within the meaning of Section 268 of the Insolvency Act 1986?(f) Has the economic operator granted a trust deed for creditors or become otherwise apparently insolvent?(g) Is the economic operator the subject of a petition presented for sequestration of its/his/her estate?(h) Has the economic operator passed a resolution within, or is it the subject of an order by the court for thewinding up of the economic operator, otherwise than for bona fide reconstruction or amalgamation?(i) Is the economic operator subject of any proceedings similar to those listed in paragraphs (a) to (g) aboveunder the laws of any other state?(j) Has been convicted of a criminal offence relating to the conduct of the economic operator's business orprofession?(k) Has the economic operator committed an act of grave misconduct in the course of that economic operator'sbusiness or profession?(l) Has failed to fulfil obligations relating to the payment of Social Security contributions under the law of theUnited Kingdom or the relevant state in which the economic operator is established?(m) Has failed its/his/her obligations relating to payment of taxes under the law of any part of the UnitedKingdom or the relevant state in which the economic operator is established?(n) Is the economic operator guilty of serious misrepresentation in providing any information required of thateconomic operator under the Public Contracts (Scotland) Regulations 2012.
Economic and financial ability
Technical capacity
Information and formalities necessary for evaluating if the requirements are met:
Please refer to the tender document for all required information.
Minimum level(s) of standards possibly required:
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure a) Potential Framework Participants must be able to demonstrate the existence of a valid and current MHRAManufacturing Specials License, or equivalent, under which all Goods tendered will be manufactured, at thedate of submission of the tender.
(b) Potential Framework Participant's Goods will be assessed against the product specification in the ITT on apass/fail basis by a representative from Scottish Pharmacy Quality Assurance Group (SPQAG).
(c) The successful Framework Participant and any sub-contractor(s) must possess valid certification of BS ENISO 9001 or equivalent.
(d) Potential Framework Participants must confirm good tendered meet the minimum stability requirements of 28days at point of manufacture.
Information about reserved contracts
Conditions specific to services contracts
Information about a particular profession
Staff responsible for the execution of the service
Section IV: Procedure
IV.1)
Type of procedure
Type of procedure
Open
Limitations on the number of operators who will be invited to tender or to participate
Reduction of the number of operators during the negotiation or dialogue
Award criteria
The most economically advantageous tender in terms of the criteria stated below
1. Price. Weighting 75
2. Product stability. Weighting 25
Information about electronic auction
An electronic auction will be used: no
File reference number attributed by the contracting authority:
NP38614
Previous publication(s) concerning the same contract
Conditions for obtaining specifications and additional documents or descriptive document
Time limit for receipt of requests for documents or for accessing documents: 1.9.2014
Time limit for receipt of tenders or requests to participate
1.9.2014 - 12:00
Date of dispatch of invitations to tender or to participate to selected candidates
Language(s) in which tenders or requests to participate may be drawn up
English.
Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
Conditions for opening of tenders
Date: 1.9.2014 - 12:00
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union OJ/S S13923/07/2014 Member states - Supply contract - Contract notice - Open procedure Place:National Procurement, 2 Swinhill Avenue, Larkhall, ML9 2QX.
Section VI: Complementary information
VI.1)
Information about recurrence
Information about European Union funds
Additional information
The estimated value range referred to sections II.1.4. and II.2.1. covers the 36 months initial duration and the full
12 month extension option. Variants will not be accepted.
(SC Ref:311788)
Procedures for appeal
Body responsible for appeal procedures
Lodging of appeals
Precise information on deadline(s) for lodging appeals: The Authority will notify economic operators who
submitted a tender or (where no de-selection notification has previously been made) applied to be selected to
tender, of its decision to award the framework agreement which notification will contain among other information,
a summary of the reasons why the economic operator was unsuccessful. The notification will incorporate a
'standstill period' of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method
used is not electronic) between the date on which the Authority despatches the notice(s) and the date on which
the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings
against the Authority during the standstill period will automatically continue the prohibition on entering into
the framework agreement until the court proceedings are determined, discontinued or disposed of, or the
court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts
before the framework agreement has been entered into include the setting aside of the decision to award the
framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after
the framework agreement has been entered into will not affect the framework agreement unless grounds for
the imposition of special penalties under the Public Contracts (Scotland) Regulations 2012 can be established.
Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered
into are limited to the award of damages. Economic operators are entitled to write to the Authority after receipt
of the notification should they require further clarification. The Authority will respond within 15 days of such a
written request, but it should be noted that receipt by the Authority of such request during the standstill period
may not prevent the Authority from awarding the framework agreement following the expiry of the standstill
period. Where an economic operator is dissatisfied with the Authority's response to its request for clarification,
or considers that the framework agreement has been concluded in breach of The Public Contracts (Scotland)
Regulations 2012, such economic operator is advised to promptly seek independent legal advice.
Service from which information about the lodging of appeals may be obtained
Date of dispatch of this notice:
18.7.2014
Member states - Supply contract - Contract notice - Open procedure Supplement to the Official Journal of the European Union

Source: http://mail.ncmps.by/data/Image/file/Large-scale-projects/3kv-2014/0dc02014_OJS139_249107_en.pdf